Protease-activated receptor PAR4 drives cardiac inflammatin in diabetes

被引：0
|
作者：
Fender, A. [1 ]
Stolte, S. [1 ]
Leineweber, K. [1 ]
Kamler, M. [2 ]
Dobrev, D. [1 ]
机构：
[1] Univ Duisburg Essen, Inst Pharmacol, Fac Med, Essen, Germany
[2] Univ Duisburg Essen, Dept Thorac & Cardiovasc Surg, Fac Med, Essen, Germany
来源：
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 2020年 / 393卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
46
引用
收藏
页码：13 / 13
页数：1
相关论文
共 50 条
  • [31] Discovery and Optimization of a Novel Series of Competitive and Central Nervous System-Penetrant Protease-Activated Receptor 4 (PAR4) Inhibitors
    Bertron, Jeanette L.
    Duvernay, Matthew T.
    Mitchell, Sidnee G.
    Smith, Shannon T.
    Maeng, Jae G.
    Blobaum, Anna L.
    Davis, Dexter C.
    Meiler, Jens
    Hamm, Heidi E.
    Lindsley, Craig W.
    ACS CHEMICAL NEUROSCIENCE, 2021, 12 (24): : 4524 - 4534
  • [32] Direct neuronal protection by the protease-activated receptor PAR4 antagonist ML354 after experimental stroke in mice
    Fleischer, M.
    Szepanowsk, R.
    Pesara, V.
    Bihorac, J. S.
    Oehler, B.
    Dobrev, D.
    Kleinschnftz, C.
    Fender, A.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2024, 397 : S69 - S69
  • [33] Protease-Activated Receptor-4 (PAR4) Activation: Evidences for Its Role and Activation in the Pathogenesis of Colitis and in Inflammatory Bowel Diseases
    Rousset, Perrine
    Cenac, Nicolas
    Balz-Hara, Daniela
    Asfaha, Samuel
    Ferraz, Jose G.
    Beck, Paul L.
    Panaccione, Remo
    Selves, Janick
    Alric, Laurent
    Vinel, Jean-Pierre
    Vergnolle, Nathalie
    GASTROENTEROLOGY, 2009, 136 (05) : A110 - A110
  • [34] Protease-activated receptor (PAR) 1 but not PAR2 or PAR4 mediates endothelium-dependent relaxation to thrombin and trypsin in human pulmonary arteries
    Hamilton, JR
    Moffatt, JD
    Frauman, AG
    Cocks, TM
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2001, 38 (01) : 108 - 119
  • [35] Inhibition of protease-activated receptor 4 (PAR4) suppresses C4a-induced invasion of lung cancer cells in vitro.
    Wang, Hongbin
    Xiong, Lingxin
    Wang, Zhibin
    Wang, Yuanyuan
    Xu, Ling
    Zhang, Weidong
    CANCER IMMUNOLOGY RESEARCH, 2020, 8 (03) : 37 - 38
  • [36] Direct neuronal protection by the protease-activated receptor PAR4 antagonist ML354 after experimental stroke in mice
    Fleischer, Michael
    Szepanowski, Rebecca D.
    Pesara, Valeria
    Bihorac, Julia Sophie
    Oehler, Beatrice
    Dobrev, Dobromir
    Kleinschnitz, Christoph
    Fender, Anke C.
    BRITISH JOURNAL OF PHARMACOLOGY, 2024, 181 (18) : 3364 - 3379
  • [37] Mapping the interaction of peptide RPPGF with the exodomain on human protease activated receptor 4 (PAR4).
    Nieman, MT
    Pagan-Ramos, E
    Warnock, M
    Krijanovski, Y
    Hasan, AAK
    Schmaier, AH
    BLOOD, 2004, 104 (11) : 511A - 512A
  • [38] Focal ischemia induces expression of protease-activated receptor1 (PAR1) and PAR3 on microglia and enhances PAR4 labeling in the penumbra
    Henrich-Noack, P
    Riek-Burchardt, M
    Baldauf, K
    Reiser, G
    Reymann, KG
    BRAIN RESEARCH, 2006, 1070 (01) : 232 - 241
  • [39] Increased expression of protease-activated receptor-2 (PAR2) and PAR4 in human coronary artery by inflammatory stimuli unveils endothelium-dependent relaxations to PAR2 and PAR4 agonists
    Hamilton, JR
    Frauman, AG
    Cocks, TM
    CIRCULATION RESEARCH, 2001, 89 (01) : 92 - 98
  • [40] Potential modulation of protease-activated receptor4 (PAR4) Threonine120 variant signalling by receptor-activity-modifying proteins (RAMPs)
    Safitri, Dewi
    Qi, Helen
    Harris, Matthew
    Ladds, Graham
    BRITISH JOURNAL OF PHARMACOLOGY, 2021, 178 (02) : 435 - 436
12345